13 Efficacy on individualized starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator-assessment (IA) in newly diagnosed advanced ovarian cancer (OC)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.